It was encouraging to see that the University of Wisconsin health system plans to study COVID-19 vaccine safety and efficacy in children under 12 ("UW Health to study COVID vaccine effects in children," Aug. 12).
In the meantime, with the surge involving children and schools reopening, parents of children under age 12 are wondering whether their pediatricians or other primary caregivers can prescribe COVID-19 vaccinations "off-label" now, as opposed to waiting for the Food and Drug Administration's decision regarding vaccinations for these youngsters, which is expected in late 2021.
Off-label use is legal and fairly common for fully approved FDA-regulated products, but not products approved only under an emergency use authorization. Full FDA vaccination approval for adults is expected next month.
I believe the FDA should consider full approval of vaccinations for adults immediately. If full FDA approval for adults is granted, parents can then — based on guidance from and the judgment of their pediatricians and other experts (and hopefully without unfairness related to inequities in access to care or coverage) — make an informed decision as to whether they wish for their under-12 child to receive a COVID-19 vaccination off-label, rather than waiting many months for this important FDA decision.
Steven Sorscher, Winston-Salem, N.C.
The writer is a physician.
•••
No parents should have to desperately search for protective face masks to keep their children safe. Yet in Monday's editorial, we read about a mom, Sarah Gollust, who is doing just that ("How to pick a better mask against COVID," Aug. 16).